ArticlePharmaceutics2023

Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study.

Susana Rojo-Tolosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.